These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


739 related items for PubMed ID: 26898456

  • 1. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ0814061), a novel microtubule inhibitor, evokes G2/M cell cycle arrest and apoptosis in human breast cancer cells.
    Xu J, Zuo D, Qi H, Shen Q, Bai Z, Han M, Li Z, Zhang W, Wu Y.
    Biomed Pharmacother; 2016 Mar; 78():308-321. PubMed ID: 26898456
    [Abstract] [Full Text] [Related]

  • 2. Novel microtubule inhibitor SQ overcomes multidrug resistance in MCF-7/ADR cells by inhibiting BCRP function and mediating apoptosis.
    Chang X, Liu Z, Cao S, Bian J, Zheng D, Wang N, Guan Q, Wu Y, Zhang W, Li Z, Zuo D.
    Toxicol Appl Pharmacol; 2022 Feb 01; 436():115883. PubMed ID: 35031325
    [Abstract] [Full Text] [Related]

  • 3. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol inhibits MDM2 and induces apoptosis in breast cancer cells through a p53-independent pathway.
    Xu J, Han M, Shen J, Guan Q, Bai Z, Lang B, Zhang H, Li Z, Zuo D, Zhang W, Wu Y.
    Cancer Lett; 2016 Dec 01; 383(1):9-17. PubMed ID: 27693458
    [Abstract] [Full Text] [Related]

  • 4. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP, Yang YX, Liu QL, Pan ST, He ZX, Zhang X, Yang T, Chen XW, Wang D, Qiu JX, Zhou SF.
    Drug Des Devel Ther; 2015 Dec 01; 9():1627-52. PubMed ID: 25834401
    [Abstract] [Full Text] [Related]

  • 5. 3-(3-Hydroxy-4-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazole (G-1103), a novel combretastatin A-4 analog, induces G2/M arrest and apoptosis by disrupting tubulin polymerization in human cervical HeLa cells and fibrosarcoma HT-1080 cells.
    Zuo D, Guo D, Jiang X, Guan Q, Qi H, Xu J, Li Z, Yang F, Zhang W, Wu Y.
    Chem Biol Interact; 2015 Feb 05; 227():7-17. PubMed ID: 25529822
    [Abstract] [Full Text] [Related]

  • 6. Methyl 5-[(1H-indol-3-yl)selanyl]-1H-benzoimidazol-2-ylcarbamate (M-24), a novel tubulin inhibitor, causes G2/M arrest and cell apoptosis by disrupting tubulin polymerization in human cervical and breast cancer cells.
    Zuo D, Jiang X, Han M, Shen J, Lang B, Guan Q, Bai Z, Han C, Li Z, Zhang W, Wu Y.
    Toxicol In Vitro; 2017 Aug 05; 42():139-149. PubMed ID: 28412508
    [Abstract] [Full Text] [Related]

  • 7. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R, Fatima I, Chandra V, Blesson CS, Kharkwal G, Hussain MK, Hajela K, Roy BG, Dwivedi A.
    Steroids; 2013 Nov 05; 78(11):1071-86. PubMed ID: 23891847
    [Abstract] [Full Text] [Related]

  • 8. 2-Methoxy-5((3,4,5-trimethosyphenyl) seleninyl) phenol causes G2/M cell cycle arrest and apoptosis in NSCLC cells through mitochondrial apoptotic pathway and MDM2 inhibition.
    Liu Y, Meng Y, Bian J, Liu B, Li X, Guan Q, Li Z, Zhang W, Wu Y, Zuo D.
    J Biochem Mol Toxicol; 2022 Jul 05; 36(7):e23066. PubMed ID: 35384151
    [Abstract] [Full Text] [Related]

  • 9. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol reverses EGF-induced cell migration and invasion through down-regulation of MDM2 in breast cancer cell lines.
    Zheng D, Chang X, Liu Y, Xu J, Gou W, Li Z, Zuo D, Zhang W, Wu Y.
    Cancer Biol Ther; 2019 Jul 05; 20(4):513-523. PubMed ID: 30514153
    [Abstract] [Full Text] [Related]

  • 10. Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway.
    Wang HY, Zhang Y, Zhou Y, Lu YY, Wang WF, Xin M, Guo XL.
    Biomed Pharmacother; 2016 Oct 05; 83():349-361. PubMed ID: 27416556
    [Abstract] [Full Text] [Related]

  • 11. ERK-modulated intrinsic signaling and G(2)/M phase arrest contribute to the induction of apoptotic death by allyl isothiocyanate in MDA-MB-468 human breast adenocarcinoma cells.
    Tsai SC, Huang WW, Huang WC, Lu CC, Chiang JH, Peng SF, Chung JG, Lin YH, Hsu YM, Amagaya S, Yang JS.
    Int J Oncol; 2012 Dec 05; 41(6):2065-72. PubMed ID: 23008020
    [Abstract] [Full Text] [Related]

  • 12. Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line.
    Ali NM, Akhtar MN, Ky H, Lim KL, Abu N, Zareen S, Ho WY, Alan-Ong HK, Tan SW, Alitheen NB, Ismail JB, Yeap SK, Kamarul T.
    Drug Des Devel Ther; 2016 Dec 05; 10():1897-907. PubMed ID: 27358555
    [Abstract] [Full Text] [Related]

  • 13. Anti-tumor activity of SL4 against breast cancer cells: induction of G2/M arrest through modulation of the MAPK-dependent p21 signaling pathway.
    Wang LH, Jiang XR, Chen GL, Guo W, Zhang JY, Cui LJ, Li HH, Li M, Liu X, Yang JY, Wu CF.
    Sci Rep; 2016 Nov 07; 6():36486. PubMed ID: 27819344
    [Abstract] [Full Text] [Related]

  • 14. Tetraarsenic hexoxide induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt suppression and p38 MAPK activation in SW620 human colon cancer cells.
    Nagappan A, Lee WS, Yun JW, Lu JN, Chang SH, Jeong JH, Kim GS, Jung JM, Hong SC.
    PLoS One; 2017 Nov 07; 12(3):e0174591. PubMed ID: 28355296
    [Abstract] [Full Text] [Related]

  • 15. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
    Pan ST, Qin Y, Zhou ZW, He ZX, Zhang X, Yang T, Yang YX, Wang D, Qiu JX, Zhou SF.
    Drug Des Devel Ther; 2015 Nov 07; 9():1601-26. PubMed ID: 25834400
    [Abstract] [Full Text] [Related]

  • 16. Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis.
    Chen J, Wang W, Wang H, Liu X, Guo X.
    Drug Discov Ther; 2014 Feb 07; 8(1):33-41. PubMed ID: 24647156
    [Abstract] [Full Text] [Related]

  • 17. Pyoluteorin induces cell cycle arrest and apoptosis in human triple-negative breast cancer cells MDA-MB-231.
    Ding T, Yang LJ, Zhang WD, Shen YH.
    J Pharm Pharmacol; 2020 Jul 07; 72(7):969-978. PubMed ID: 32246778
    [Abstract] [Full Text] [Related]

  • 18. LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells.
    Zhao Y, Wang X, Sun Y, Zhou Y, Yin Y, Ding Y, Li Z, Guo Q, Lu N.
    Apoptosis; 2015 Sep 07; 20(9):1253-69. PubMed ID: 26153346
    [Abstract] [Full Text] [Related]

  • 19. RPF101, a new capsaicin-like analogue, disrupts the microtubule network accompanied by arrest in the G2/M phase, inducing apoptosis and mitotic catastrophe in the MCF-7 breast cancer cells.
    de-Sá-Júnior PL, Pasqualoto KF, Ferreira AK, Tavares MT, Damião MC, de Azevedo RA, Câmara DA, Pereira A, de Souza DM, Parise Filho R.
    Toxicol Appl Pharmacol; 2013 Feb 01; 266(3):385-98. PubMed ID: 23238560
    [Abstract] [Full Text] [Related]

  • 20. Anticancer activity of Eremanthin against the human cervical cancer cells is due to G2/M phase cell cycle arrest, ROS-mediated necrosis-like cell death and inhibition of PI3K/AKT signalling pathway.
    Liu T, Zhao X, Song D, Liu Y, Kong W.
    J BUON; 2020 Feb 01; 25(3):1547-1553. PubMed ID: 32862603
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.